A new vaccine against typhoid has been proven to be safe and effective in preventing the disease, and can be used to protect both adults and children.
A study published in the Lancet is the first clinical trial to show that immunisation with the typhoid conjugate vaccine (TCV) or Typbar-TCV is safe, well tolerated and will have significant impact on disease incidence in endemic areas that introduce it.
